Applications Published 21 November 2001
Published: 1-Jul-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Method for inhibiting transplant rejection
Faustman, Denise 1154686*
Method for preparation of pharmaceutical-grade dithiocarbamate
Medinox 1154689*
Targeted transscleral controlled release drug delivery to the retina and choroid
Massachusetts Eye and Ear Infirmary 1154691*
A method of controlling fungal pathogens, and agents useful for same
The Australian National University 1154692*
Liposome formulations
Optime Therapeutics; Blue Ridge Pharmaceuticals 1154755*
Antibody fragment-targeted immunoliposomes for systemic gene delivery
Georgetown University; Synergene Therapeutics 1154756*
Fast dispersing dosage forms free of gelatin
RP Scherer 1154757*
Controlled release formulation for treating COPD
SmithKline Beecham 1154758*
Disposable concentrate for the delivery of cyclosporin
Dexcel 1154759*
Biodegradable composite material for the production of microcapsules
Bioserv 1154760*
Solid oral dosage form containing an enhancer
Elan Corp 1154761*
Pharmaceutical capsule compsns containing loratadine and pseudoephedrine
Yuhan Corp 1154762*
Patch for transdermal therapy
Jehan, David 1154763*
Epoxide hydrolase complexes and methods therewith
The Regents of the University of California 1154764*
Effervscent laxatives
SmithKline Beecham 1154765*
Use of R-aryl propionic acids for producing medicaments to treat diseases in humans and animals, whereby said diseases can be therapeutically influenced by inhibiting the activation of NF-kappa B
PAZ Arzneimittel-Entwicklungsgesellschaft 1154766*
Substituted stilbene compounds with vascular damaging activity
Angiogene Pharmaceuticals 1154767*
Gabapentin derivative for preventing and treating visceral pain
Warner-Lambert 1154768*
A novel anti-angiogenic agents comprising at least one kringle region and an upstream pre-activation domain of plasminogen
Bristol-Myers Squibb 1154769*
Premixed formulation of piperacillin sodium and tazobactam sodium injection
Baxter international 1154770*
Nitrosated and nitrosylated proton pump inhibitors, compsns and methods of use
Nitromed 1154771*
Agent for use in transplantation
Lundblad, Leif 1154772*
Use of antagonists of PG-E for the treatment of neuropathic pain
AstraZeneca 1154773*
Quinazoline derivatives as angiogenesis inhibitors
AstraZeneca; Zeneca-Pharma 1154774*
Therapeutic aqueous compsn containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
Warner-Lambert 1154775*
Pharmaceutical compsn containing desoxypeganine for the treatment of alcoholism
LTS Lohmann Therapie-Systeme 1154776*
Medicament for treating hypertension
Solvay Pharmaceuticals 1154777*
Pharmaceutical preparation containing dithranol
Esparma 1154778*
Treatment regimen for prostate cancer, initiated after androgen ablative treatment has started
Napro Biotherapeutics 1154779*
Bone marrow transplantation for hepatic regeneration and repair
University of Pittsburgh of the Commonwealth System of Higher Education 1154780*
Preparation for regulating lower bowel function
Baylabs 1154781*
Taxane derivatives for targeted therapy of cancer
The UAB Research Foundation 1154782*
Medicaments comprising relaxin and their use
Lurie, Raziel 1154783*
Therapeutically active mixture of substances containing S-acetylglutathione and aciclovir
Treusch, Gernot 1154784*
Inhibitors for use in haemostasis and immune function
ZymoGenetics 1154785*
Methods and compsns for altering mucus secretion
North Carolina State University 1154786*
Synergistic combination for treatment of viral-mediated diseases
Institute of Molecular and Cell Biology 1154787*
Inhibitors of separin, method for identifying them and uses
Boehringer Ingelheim 1154788*
Caulobacter LPS immunoadjuvant
University of British Columbia 1154789*
Enhancement of bactericidal activity of Neisseria antigens with oligonucleotides containing CG motifs
Chiron 1154790*
Neisserial vaccine compsns and methods
Microbiological Research Authority, Centre for Applied Microbiology and Research; Imperial College of Science, Technology and Medicine 1154791*
Tuberculosis vaccine formulation comprising monoglycerides or fatty acid as adjuvant
Eurocine 1154792*
Use of bioadhesives and adjuvants for the mucosal delivery of antigens
Chiron 1154793*
Agent containing an additional local anaesthetic for the treatment of Parkinson's disease
Saiger, Lothar 1154794*
Method of treating and diagnosing restless legs syndrome and corrseponding means
Hedner, Jan; Kraiczi, Holger 1154795*
Novel albumin-free Factor VIII formulations
The University of Connecticut; Baxter international 1154796*
Multi-mutant diphtheria toxin vaccines
President and Fellows of Harvard College 1154797*
Molecules for the diagnosis and treatment of tumours
Mallinckrodt 1154798*
Biotinylated-chemokine antibody complexes
Millennium Pharmaceuticals 1154799*
Dry acid-chitosan complexes
DCV 1154800*
